• Citer

Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): Subgroup analysis from the AMBITION trial

par Coghlan, John Gerry;Simonneau, Gerald;Vachiery, Jean-Luc ;Blair, Christiana;Gillies, Hunter;Miller, Karen K.L.;Harris, Julia H N;Langley, Jonathan;Rubin, Lewis;Galie, Nazzareno;Barberà, Joan Albert;Frost, Adaani;Ghofrani, Hossein Ardeschir;Hoeper, Marius M.;Kuwana, Masataka;McLaughlin, Vallerie;Peacock, Andrew J.
Référence Annals of the Rheumatic Diseases, 76, 7, page (1219-1227)
Publication Publié, 2017-07

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): Subgroup analysis from the AMBITION trial
Auteur:	Coghlan, John Gerry; Simonneau, Gerald; Vachiery, Jean-Luc; Blair, Christiana; Gillies, Hunter; Miller, Karen K.L.; Harris, Julia H N; Langley, Jonathan; Rubin, Lewis; Galie, Nazzareno; Barberà, Joan Albert; Frost, Adaani; Ghofrani, Hossein Ardeschir; Hoeper, Marius M.; Kuwana, Masataka; McLaughlin, Vallerie; Peacock, Andrew J.
Informations sur la publication:	Annals of the Rheumatic Diseases, 76, 7, page (1219-1227)
Statut de publication:	Publié, 2017-07
Sujet CREF:	Allergie et immunopathologie
	Rhumatologie
	Immunologie
	Biologie
Mots-clés:	Arterial Hypertension
	Systemic Sclerosis
	Treatment
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0003-4967
	info:doi/10.1136/annrheumdis-2016-210236
	info:scp/85010425197